Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bontkes, Hetty J.
de Gruijl, Tanja D.
Bijl, Astrid
Verheijen, René H. M.
Meijer, Chris J. L. M.
Scheper, Rik J.
Stern, Peter L.
Burns, Julie E.
Maitland, Norman J.
and
Walboomers, Jan M. M.
1999.
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia.
Journal of General Virology
,
Vol. 80,
Issue. 9,
p.
2453.
Rees, L.
Birchall, M.
Bailey, M.
and
Thomas, S.
2004.
A systematic review of case-control studies of human papillomavirus infection in laryngeal squamous cell carcinoma.
Clinical Otolaryngology and Allied Sciences,
Vol. 29,
Issue. 4,
p.
301.
Waller, Jo
McCaffery, Kirsten J.
Forrest, Sue
and
Wardle, Jane
2004.
Human papillomavirus and cervical cancer: Issues for biobehavioral and psychosocial research.
Annals of Behavioral Medicine,
Vol. 27,
Issue. 1,
p.
68.
Crosbie, Emma J.
and
Kitchener, Henry C.
2006.
Human papillomavirus in cervical screening and vaccination.
Clinical Science,
Vol. 110,
Issue. 5,
p.
543.
Visser, Jeroen
van Baarle, Debbie
Hoogeboom, Baukje Nynke
Reesink, Nathalie
Klip, Harry
Schuuring, Ed
Nijhuis, Esther
Pawlita, Michael
Bungener, Laura
de Vries‐Idema, Jacqueline
Nijman, Hans
Miedema, Frank
Daemen, Toos
and
van der Zee, Ate
2006.
Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.
International Journal of Cancer,
Vol. 118,
Issue. 10,
p.
2529.
Song, Seung-Hun
Lee, Jae-Kwan
Seok, Oye-Sun
and
Saw, Ho-Suk
2007.
The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
Gynecologic Oncology,
Vol. 104,
Issue. 3,
p.
732.
Arbyn, Marc
and
Dillner, Joakim
2007.
Review of current knowledge on HPV vaccination: An Appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Journal of Clinical Virology,
Vol. 38,
Issue. 3,
p.
189.
Kloth, JN
Gorter, A
Fleuren, GJ
Oosting, J
Uljee, S
Haar, N ter
Dreef, EJ
Kenter, GG
and
Jordanova, ES
2008.
Elevated expression of SerpinA1 and SerpinA3 in HLA‐positive cervical carcinoma.
The Journal of Pathology,
Vol. 215,
Issue. 3,
p.
222.
Antoni, Michael H.
Pereira, Deidre B.
Marion, Ilona
Ennis, Nicole
Andrasik, Michele Peake
Rose, Rachel
McCalla, Judith
Simon, Trudi
Fletcher, Mary Ann
Lucci, Joseph
Efantis-Potter, Jonell
and
O'Sullivan, Mary Jo
2008.
Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women.
Journal of Psychosomatic Research,
Vol. 65,
Issue. 4,
p.
389.
Dillner, J
Arbyn, M
Unger, E
and
Dillner, L
2010.
Monitoring of human papillomavirus vaccination.
Clinical and Experimental Immunology,
Vol. 163,
Issue. 1,
p.
17.
Milutin Gašperov, Nina
Farkas, Sanja A.
Nilsson, Torbjörn K.
and
Grce, Magdalena
2014.
Epigenetic activation of immune genes in cervical cancer.
Immunology Letters,
Vol. 162,
Issue. 2,
p.
256.
Alsanea, Madain
Alsaleh, Asma
Obeid, Dalia
Alhadeq, Faten
Alahideb, Basma
and
Alhamlan, Fatimah
2022.
Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia.
Viruses,
Vol. 15,
Issue. 1,
p.
109.